Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients
Authors
Keywords
Calprotectin, MRP8/14, Cardiovascular disease, Inflammation, Type 2 diabetes, Obesity, Metabolic syndrome, Automated assay, Reference range
Journal
BMC Cardiovascular Disorders
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-18
DOI
10.1186/1471-2261-14-196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice
- (2012) Ryohei Sekimoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High serum S100A8/A9 levels and high cardiovascular complication rate in type 2 diabetics with ultrasonographic low carotid plaque density
- (2012) Ayumu Hirata et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes
- (2012) Francisco J Ortega et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
- (2011) Renata Micha et al. AMERICAN JOURNAL OF CARDIOLOGY
- Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients
- (2011) Wen Peng et al. Cardiovascular Diabetology
- Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
- (2011) Mikael K Poulsen et al. Cardiovascular Diabetology
- MRP8/14 is associated with systemic inflammation in stable coronary atherosclerosis in men
- (2011) Marcus Baumann et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Unknown
- (2011) Victoria Catalan et al. MOLECULAR MEDICINE
- Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy
- (2009) Klaus Burkhardt et al. Cardiovascular Diabetology
- Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury
- (2009) Kevin Croce et al. CIRCULATION
- The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
- (2009) Jan M. Ehrchen et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients
- (2009) Mikael K. Poulsen et al. JOURNAL OF NUCLEAR CARDIOLOGY
- Neutrophil Activation in Morbid Obesity, Chronic Activation of Acute Inflammation
- (2009) Jeroen Nijhuis et al. Obesity
- Calprotectin — A Novel Marker of Obesity
- (2009) Ole Hartvig Mortensen et al. PLoS One
- Binding of S100 proteins to RAGE: An update
- (2008) Estelle Leclerc et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial
- (2007) David A. Morrow et al. AMERICAN HEART JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started